Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brett P Monia

Showing results (61-70 of 147) with videos related to

Pageof 15
Sort By:
The Prostate|October 1, 2009
Antisense oligonucleotide targeting of insulin-like growth factor-1 receptor (IGF-1R) in prostate cancerJunya Furukawa, Christopher J Wraight, Susan M Freier, et al.
Carcinogenesis|December 8, 2005
Raf-1 is the predominant Raf isoform that mediates growth factor-stimulated growth in ovarian cancer cellsFiona McPhillips, Peter Mullen, Kenneth G MacLeod, et al.
Blood|August 9, 2011
Selective depletion of plasma prekallikrein or coagulation factor XII inhibits thrombosis in mice without increased risk of bleedingAlexey S Revenko, Dacao Gao, Jeff R Crosby, et al.
Nucleic Acid Therapeutics|April 15, 2020
Population Pharmacokinetic-Pharmacodynamic Modeling of Inotersen, an Antisense Oligonucleotide for Treatment of Patients with Hereditary Transthyretin AmyloidosisRosie Z Yu, Jon W Collins, Shannon Hall, et al.
Nature Communications|June 8, 2017
Antisense oligonucleotide-mediated Dnm2 knockdown prevents and reverts myotubular myopathy in miceHichem Tasfaout, Suzie Buono, Shuling Guo, et al.
International Journal of Molecular Sciences|September 10, 2021
In Vitro and In Vivo Effects of SerpinA1 on the Modulation of Transthyretin ProteolysisFilipa Bezerra, Christoph Niemietz, Hartmut H J Schmidt, et al.
Nucleic Acids Research|December 22, 2006
Antisense oligonucleotides containing locked nucleic acid improve potency but cause significant hepatotoxicity in animalsEric E Swayze, Andrew M Siwkowski, Edward V Wancewicz, et al.
Diabetes|January 30, 2004
Reduction in glucagon receptor expression by an antisense oligonucleotide ameliorates diabetic syndrome in db/db miceYin Liang, Melville C Osborne, Brett P Monia, et al.
Experimental Cell Research|August 10, 2020
SERPINA1 modulates expression of amyloidogenic transthyretinChristoph Niemietz, Filipa Bezerra, Maria Rosário Almeida, et al.
Molecular Cancer Therapeutics|January 11, 2011
Transcription factor Stat5 knockdown enhances androgen receptor degradation and delays castration-resistant prostate cancer progression in vivoChristian Thomas, Amina Zoubeidi, Hidetoshi Kuruma, et al.
Pageof 15

Showing results (61-70 of 147) with videos related to

Sort By:
Pageof 15
The Prostate|October 1, 2009
Antisense oligonucleotide targeting of insulin-like growth factor-1 receptor (IGF-1R) in prostate cancerJunya Furukawa, Christopher J Wraight, Susan M Freier, et al.
Carcinogenesis|December 8, 2005
Raf-1 is the predominant Raf isoform that mediates growth factor-stimulated growth in ovarian cancer cellsFiona McPhillips, Peter Mullen, Kenneth G MacLeod, et al.
Blood|August 9, 2011
Selective depletion of plasma prekallikrein or coagulation factor XII inhibits thrombosis in mice without increased risk of bleedingAlexey S Revenko, Dacao Gao, Jeff R Crosby, et al.
Nucleic Acid Therapeutics|April 15, 2020
Population Pharmacokinetic-Pharmacodynamic Modeling of Inotersen, an Antisense Oligonucleotide for Treatment of Patients with Hereditary Transthyretin AmyloidosisRosie Z Yu, Jon W Collins, Shannon Hall, et al.
Nature Communications|June 8, 2017
Antisense oligonucleotide-mediated Dnm2 knockdown prevents and reverts myotubular myopathy in miceHichem Tasfaout, Suzie Buono, Shuling Guo, et al.
International Journal of Molecular Sciences|September 10, 2021
In Vitro and In Vivo Effects of SerpinA1 on the Modulation of Transthyretin ProteolysisFilipa Bezerra, Christoph Niemietz, Hartmut H J Schmidt, et al.
Nucleic Acids Research|December 22, 2006
Antisense oligonucleotides containing locked nucleic acid improve potency but cause significant hepatotoxicity in animalsEric E Swayze, Andrew M Siwkowski, Edward V Wancewicz, et al.
Diabetes|January 30, 2004
Reduction in glucagon receptor expression by an antisense oligonucleotide ameliorates diabetic syndrome in db/db miceYin Liang, Melville C Osborne, Brett P Monia, et al.
Experimental Cell Research|August 10, 2020
SERPINA1 modulates expression of amyloidogenic transthyretinChristoph Niemietz, Filipa Bezerra, Maria Rosário Almeida, et al.
Molecular Cancer Therapeutics|January 11, 2011
Transcription factor Stat5 knockdown enhances androgen receptor degradation and delays castration-resistant prostate cancer progression in vivoChristian Thomas, Amina Zoubeidi, Hidetoshi Kuruma, et al.
Pageof 15